Developing novel pharmaceutical technology that provides for outstanding taste masking for a broad range of pharmaceuticals including major drug categories such as NSAIDS and statins.
| Currency | UK Pounds |
| Price | 1.48p ![]() |
| Change Today | -0.025p |
| Volume | 914,901 |
| 06-Feb-12 Close | 1.48p |
| Shares Issued | 577.02m |
| Market Cap | £8.51m |
| Appointment of Business Development Partner | 30-Jan-2012 | 07:00 | RNS |
| New Orders | 19-Dec-2011 | 07:00 | RNS |
| Commencement of Distribution Agreement | 15-Dec-2011 | 07:00 | RNS |
| Holding(s) in Company | 22-Nov-2011 | 14:20 | RNS |
| Launch of OxpZero | 22-Nov-2011 | 07:00 | RNS |
This is a solution provided by Digital Look Corporate Solutions incorporating their prices, data, charts, fundamentals and investor tools on this site. Terms & Conditions